EGF/EGFR activation results in the separation of SHC‐binding protein 1 (SHCBP1) from SHC adaptor protein 1 (SHC1), which then translocates to the nucleus and promotes cancer development via multiple signaling pathways.172. Here, SHC1 is linked to cancer.